Scientists at the Massachusetts Institute of Technology (MIT) may be on the cusp of making a new vaccine to combat a rise in the world's deadliest disease, which takes 1million lives worldwide.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators will present data showing the critical role of blood-based testing ...

ALBUQUERQUE, N.M. (AP) — It’s a name many people have trouble pronouncing, but these synthetic chemicals have been used in everything from fast-food packaging to nonstick cookware, clothing, household ...

The innovative platform will provide near-real-time access to TB testing and case data from across South Africa, marking a major stride in the country’s efforts to reduce TB incidence and mortality by ...

Maria Menounos knows first-hand the importance of early cancer detection. The host of the wellness podcast Heal Squad, 47, was recovering from a brain tumor in 2022 when she began struggling with ...

Labcorp Holdings said it would soon offer a blood test for diagnosing Alzheimer's disease in primary-care settings. The Burlington, N.C., lab-services company on Thursday said the Elecsys pTau181 test ...

Scientists from the University of Exeter has developed a precise method to interpret ankle blood pressure readings—an innovation that could transform care for people unable to have their arm blood ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. BERLIN — For years, scientists have held out hope that tests that look ...

Man gropes, attacks store's customers, then female shopper fatally shoots him, authorities say Islamist extremists have taken this country to the brink Tropical Storm Melissa spaghetti models show ...

CLOVIS, N.M. (KRQE) – The New Mexico Environment Department and New Mexico Department of Health are hosting a public meeting in Clovis to share results from a first-of-its-kind blood testing project ...

A blood test that screens for more than 50 cancers is correct in 62% of cases where it thinks people may have the disease, a study has found. The Galleri test, which can be given annually and is ...